Vazegepant是一种高效、选择性且结构独特的小分子 CGRP 受体拮抗剂。

Galcanezumab是一种人源化IgG4单克隆抗体，通过与CGRP结合来阻止其与受体结合。Galcanezumab具有用于偏头痛预防的潜力。

Rimegepant是一种高效口服降钙素基因相关肽（CGRP）受体拮抗剂，Ki 值为 0.027 nM。

Calcitonin salmon is a calcium regulating hormone secreted from mammalian thyroid parafollicular cells and in non-mammalian species from the ultimobranchial gland.

α-CGRP 是一种含有 37 个氨基酸的调节性神经肽，广泛分布于中枢神经系统和周围神经系统，是一种有效的血管扩张药。

Olcegepant is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor (IC50= 0.03 nM).

Atogepant 是一种口服有效且具有选择性的降钙素基因相关肽受体 (CGRP) 拮抗剂，用于预防性治疗发作性偏头痛。

Rat CGRP-(8-37) is a highly selective antagonist of CGRP receptor.

Ubrogepant is an oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.

Fremanezumab是一种人源化IgG2单克隆抗体，通过与CGRP结合来阻止其与受体结合。Fremanezumab具有用于偏头痛预防的潜力。

α-CGRP(8-37), human is a human calcitonin gene-related peptide (hCGRP) fragment and also an antagonist of CGRP receptor.

Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist.